Hydronephrosis Clinical Trial
Official title:
A Pilot Pre-Surgical Study Evaluating Anti-PD-L1 Antibody (Durvalumab) Plus Anti-CTLA-4 (Tremelimumab) in Patients With Muscle-Invasive, High-Risk Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Neoadjuvant Chemotherapy
This pilot phase I trial studies the side effects of durvalumab and tremelimumab in treating patients with muscle-invasive, high-risk urothelial cancer that cannot be treated with cisplatin-based therapy before surgery. Immunotherapy with monoclonal antibodies, such as durvalumab and tremelimumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread.
PRIMARY OBJECTIVES: I. To evaluate the safety and tolerability of durvalumab and tremelimumab in patients with muscle-invasive, high-risk bladder cancer who are ineligible for neoadjuvant cisplatin-containing chemotherapies. SECONDARY OBJECTIVES: I. To assess immunologic/molecular responses (e.g. peripheral blood cluster of differentiation [CD] 4+inducible T-cell co-stimulator [ICOS]+ T cells) to durvalumab and tremelimumab in patients with muscle-invasive, high-risk bladder cancer who are ineligible for neoadjuvant cisplatin-containing chemotherapies. II. To evaluate pathologic T0 rate after neoadjuvant treatment with durvalumab and tremelimumab in patients with muscle-invasive, high-risk bladder cancer comparing to historical data (about 10% in patients with high-risk disease). III. To evaluate relapse-free survival (RFS) and overall survival (OS). OUTLINE: Patients receive tremelimumab intravenously (IV) over 1 hour and durvalumab IV over 1 hour on day 1 of weeks 1 and 4. Beginning 4-6 weeks after the last infusion, patients undergo cystectomy with pelvic lymph node dissection surgery. After completion of study treatment, patients are followed up at 90 days, and then every 3 months for up 1 year. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01349244 -
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
|
N/A | |
Recruiting |
NCT04090255 -
Us vs Fluoroscopic Guided Renal Access
|
N/A | |
Completed |
NCT03296280 -
Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
|
||
Completed |
NCT03327688 -
Point-of-care Ultrasound in Finland
|
N/A | |
Completed |
NCT02976870 -
Hydronephrosis After Anterior Lumbar Interbody Fusion (ALIF)
|
N/A | |
Completed |
NCT01781845 -
Hydronephrosis ARFI Study
|
N/A | |
Completed |
NCT00555308 -
Emergency Department Targeted Ultrasound for the Detection of Hydronephrosis
|
N/A | |
Completed |
NCT03873701 -
Bedside Ultrasonography in Acute Patients With Suspected Kidney Involvement
|
||
Suspended |
NCT03774719 -
Hand-carried Ultrasound to Assess Hydronephrosis
|
N/A | |
Completed |
NCT04869462 -
DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)
|
||
Not yet recruiting |
NCT03695991 -
Effect of Per-cutaneous Nephrosotomy Drainage on Radioisotope Imaging of Hydronephrotic Kidneys
|
||
Completed |
NCT01323842 -
Emergency Department Ultrasound in Renal Colic
|
N/A | |
Completed |
NCT00882544 -
Prospective Pediatric Pyeloplasty Robotic Surgical Database
|
N/A | |
Completed |
NCT00231322 -
Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique
|
N/A | |
Completed |
NCT01839006 -
Clinical Significance of Supranormal Differential Renal Function in the Recovery of Hydronephrosis
|
N/A | |
Recruiting |
NCT04250090 -
Post-Marketing Follow-Up of Long-term Type Ureteral Stent Set
|
||
Recruiting |
NCT05455307 -
Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture
|
N/A | |
Active, not recruiting |
NCT01140516 -
Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis
|
N/A | |
Completed |
NCT04594161 -
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
|
N/A | |
Completed |
NCT00591968 -
Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community
|
N/A |